Table 4.
Association between conjunctivitis and laboratory investigations in patients with COVID-19.
| Characteristics | Total (n=186) | Conjunctivitis (n=25) | No conjunctivitis (n=161) | P |
|---|---|---|---|---|
| C-reactive protein (mg/mL) | 11.0 (15.0, 1.0–66.0) | 11.0 (17.50, 1.0–44.0) | 11.0 (13.50, 2.0–66.0) | .927 |
| D-dimer (ng/mL) | 395.0 (450.0, 45.0–3200.0) | 300.0 (435.0, 100.0–1200.0) | 400.0 (440.0, 45.0–3200.0) | 293 |
| Serum ferritin (ng/mL) | 140.0 (202.5, 20.0–1000.0) | 150.0 (155.0, 30.0–450.0) | 130.0 (210.0, 20.0–1000.0) | .884 |
| Lactate dehydrogenase (ug/L) | 100.0 (140.0, 25.0–350.0) | 200.0 (185.0, 50.0–340.0) | 100.0 (130.0, 25.0–350.0) | .040 |
| Absolute lymphocyte count (×109/L) | 1.0 (0.50, .50–2.10) | 1.0 (0.45, .60–1.60) | 1.0 (0.55, .50–2.10) | .350 |
Data are median (interquartile range, minimum-maximum).